Our success is built on our clients’ success. We have a long and distinguished history of supporting our clients wherever they do business, from major financial centers to emerging and growth markets. We represent many of the world’s leading corporations and major financial institutions, as well as emerging growth companies, governments and state-owned enterprises, often working on ground-breaking, precedent-setting matters. With a deep understanding of our clients' businesses and the industries they operate in, our work is driven by their need for outstanding legal and commercial advice.
On January 28, 2015, the International Organization of Securities Commissions published its final report on risk mitigation standards for non-centrally cleared OTC derivatives...
On January 28, 2015, the International Organization of
Securities Commissions ("IOSCO") published its final
report on risk mitigation standards for non-centrally cleared OTC
derivatives, setting out nine standards to help strengthen the
non-centrally cleared OTC derivatives market. The standards include
risk mitigation techniques relating to trade confirmation,
valuation with counterparties, dispute resolution and cross-border
transactions, and aim, amongst other issues, to enhance legal
certainty over the terms of non-centrally cleared OTC derivatives
transactions and shorten the amount of time it may take to resolve
disputes.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
